Recombinant Mouse Chemokine-binding protein 2 (Ccbp2)

What is Recombinant Mouse Chemokine-binding Protein 2 (Ccbp2) and its biological significance?

Recombinant Mouse Chemokine-binding Protein 2 (Ccbp2), also known as ACKR2, belongs to the atypical chemokine receptor family. Unlike canonical chemokine receptors that signal through G-proteins, ACKR2 functions primarily as a scavenger receptor, modulating chemokine levels by internalizing and degrading them. This mechanism plays a critical role in maintaining inflammatory balance within tissues, particularly at sites of immune activation such as the maternal-fetal interface during pregnancy .

Ccbp2 has been implicated in various physiological and pathological processes, including immune regulation, inflammation suppression, and tissue remodeling. For instance, its expression in placental trophoblast cells highlights its role in mitigating immune overactivation at the maternal-fetal interface during pregnancy-related conditions like preeclampsia .

How is Ccbp2 expressed and purified in recombinant systems?

Recombinant Ccbp2 is typically expressed in bacterial systems such as Escherichia coli. The protein is engineered to include specific domains necessary for its function, such as glycosaminoglycan (GAG)-binding sites. Purification methods involve affinity chromatography techniques like His-tag purification, followed by validation using SDS-PAGE to ensure purity levels exceeding 95% .

For example, recombinant mouse Ccbp2 produced via E. coli expression systems includes residues Ala28-Asn100, with a molecular weight of approximately 7.9 kDa. Lyophilized formulations are stabilized with buffers containing Tris and NaCl at pH 8.0 . These formulations are stored at -20°C to -80°C for long-term stability.

What experimental models are commonly used to study Ccbp2?

Experimental models for studying Ccbp2 include:

• Cell-based assays: These involve transfecting cell lines with siRNA targeting Ccbp2 to observe changes in proliferation, migration, and invasion behaviors .

• Animal models: Mouse models are used to investigate the role of Ccbp2 in inflammation and disease pathogenesis.

• Bioinformatics approaches: Weighted Gene Co-expression Network Analysis (WGCNA) has been employed to identify Ccbp2 as a hub gene associated with specific conditions such as preeclampsia .

What are the primary methods for detecting and quantifying Ccbp2?

Detection and quantification of recombinant Ccbp2 involve several techniques:

• Western Blotting: Using specific antibodies against Ccbp2, researchers can assess protein expression levels in various tissues or cell lysates .

• ELISA: Enzyme-linked immunosorbent assays provide quantitative measurements of Ccbp2 concentration in biological samples.

• Mass Spectrometry: This technique offers high-resolution identification and quantification of post-translational modifications on recombinant proteins .

What are the known physiological roles of Ccbp2?

Ccbp2 regulates inflammatory responses by scavenging chemokines such as CXCL1 and CXCL8. This activity prevents excessive immune activation during inflammatory diseases, including glomerulonephritis and pulmonary inflammation . Additionally, its expression in placental tissues suggests a role in maintaining maternal-fetal immune tolerance during pregnancy .

How does Ccbp2 contribute to inflammatory disease pathogenesis?

Ccbp2 modulates inflammation by clearing chemokines from extracellular spaces, thereby reducing immune cell recruitment to inflamed tissues. Dysregulation of this mechanism has been linked to exacerbated inflammatory responses in conditions such as preeclampsia . Experimental studies have shown that knockdown of Ccbp2 increases trophoblast cell proliferation and migration, suggesting its role in controlling placental inflammation .

What are the molecular mechanisms underlying GAG binding in Ccbp2?

Ccbp2 contains specialized domains that interact with glycosaminoglycans (GAGs), facilitating chemokine scavenging. These interactions are distinct from those observed in other chemokines, involving oligomerization on GAGs . Biochemical analyses reveal that these domains exhibit high affinity for sulfated GAGs like heparan sulfate.

Table: Characteristics of GAG Binding Domains in Recombinant Mouse Chemokine-binding Proteins

How can bioinformatics tools be used to identify novel roles for Ccbp2?

Bioinformatics tools like WGCNA enable researchers to identify hub genes associated with specific diseases by analyzing co-expression networks . For example:

• Network Analysis: Cytoscape software visualizes gene interaction networks.

• Algorithmic Approaches: CytoHubba's MCC and DMNC algorithms pinpoint critical nodes like Ccbp2 within large datasets.

• Validation: Public datasets confirm upregulation of Ccbp2 in disease states such as preeclampsia.

These methods provide insights into how Ccbp2 interacts with other genes involved in immune regulation.

What experimental strategies can clarify the functional roles of Ccbp2?

Experimental strategies include:

• Gene Knockdown Studies: siRNA-mediated knockdown of Ccbp2 reveals its role in trophoblast cell behavior.

• Chemokine Clearance Assays: Assessing the efficiency of chemokine degradation by recombinant Ccbp2.

• Inflammatory Models: Using mouse models to study the impact of Ccbp2 deficiency on inflammation progression.

These approaches help elucidate the multifaceted roles of Ccbp2 in health and disease.

How does the structural configuration of recombinant Ccbp2 affect its function?

The structural configuration of recombinant proteins influences their binding affinity and specificity for ligands like chemokines or GAGs . Structural studies using X-ray crystallography or NMR spectroscopy reveal that mutations within binding domains can alter scavenging efficiency.